The effect of Bacillus coagulans MTCC 5856(LactoSporeÂ®) on the modulation of gut microflora and its fecal recovery in healthy human subjects: A randomized double blind placebo controlled clinical trial.

Sami Labs Limited0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1 BMI between 20-27 kg/m2 (both inclusive).
•2 Non vegetarians and Non smokers
•3 Willing to come for regular follow â??up visits.
•4 Able to give written informed consent.
•5 Willing to avoid the prebiotic and probiotic food supplements, laxatives and foods having laxative effects during the study.

•1 Use of antibiotics.
•2 Any underlying gastrointestinal complaints like colonic irritation.
•3 Not taking any medication with gastrointestinal activity like laxatives.
•4 Had not taken antibiotics for 3 months prior to starting the study.
•5 Consumption of Yogurt, curd, prebiotic or probiotic supplements as part of their daily diet.
•6 Participation in a clinical study during the preceding 90 days.
•7 Not willing to abide by the study procedures or not willing to provide stool samples for the study.
•8 Pregnancy and lactating.
•9 Presently suffering from any inflammatory disorders and mental illness.
•10 History of drug or alcohol abuse in the last 6 months.

发起方

Sami Labs Limited